Loomis, Sayles & Company’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-536,920	Closed	-$24.1M	–	922
2021 Q2	$24.1M	Buy	+536,920	New	+$24.1M	0.03%	278